DRUG
Bright Minds·NASDAQ
--
--(--)
--
--(--)
DRUG Filings
Filing Date
Form Description
Form Type
2026-02-06
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-06 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-09
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-09 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-09
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-09 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-09
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-09 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-07
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-07 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-07
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-07 ·
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026-01-07
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-07 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
